Searched for
PFIZER COVID DRUG
US market today: Pfizer posts strong first-quarter, sees boost from recent legal winsPfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...
Why is PFE stock falling today despite beating Pfizer's earnings estimates? Key factors investors are watchingPFE stock today: Pfizer's stock dipped despite strong fourth-quarter earnings. Investors reacted to the company's modest 2026 outlook. Decl...
China approves use of Pfizer's COVID drug PaxlovidThe National Medical Products Administration said Paxlovid is approved to treat adults who have mild to moderate COVID-19 and high risk of ...
Pfizer's COVID product sales to top $50 billion this year, investors want moreAlthough Pfizer raised its forecast for the vaccine, developed with Germany's BioNTech SE, by $1 billion to $32 billion, the drugmaker caut...
How does Merck's COVID-19 pill compare to Pfizer's?Merck in November said its full trial results showed that molnupiravir lowered the chance of hospitalization or death by about 30% in patie...
Pfizer may offer Covid antiviral drug to India at lower price for nowPfizer has entered into advance purchase agreements with multiple countries. Sources told ET that Pfizer is yet to apply for emergency use ...
Bangladeshi firm launches first generic of Pfizer drugBangladesh's directorate general of drug administration on Thursday granted emergency use authorisation for the oral antiviral drug to trea...
Bangladesh drug maker Beximco launches world's first generic of Pfizer's COVID antiviralPfizer's novel antiviral pill showed almost 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent data f...
U.S. FDA authorizes Merck's at-home antiviral COVID-19 pillMerck's drug, molnupiravir, developed with Ridgeback Biotherapeutics, was shown to reduce hospitalizations and deaths by around 30% in a cl...
Pfizer pill becomes 1st US-authorized home COVID treatmentData from Pfizer's clinical trial showed its two-drug antiviral regimen was 90% effective in preventing hospitalizations and deaths in pati...
Pfizer confirms COVID pill's results, potency versus omicronThe Food and Drug Administration is expected to soon rule on whether to authorize Pfizer's pill and a competing pill from Merck, which was ...
Pfizer Inc signs $5.3 billion COVID-19 pill deal with US govtThe company earlier this month said the drug cut by 89% the chance of hospitalization or death for adults at risk of severe disease. The tr...
Local firms gear up to seek licence for Pfizer's Covid drugUS drug giant Pfizer on Tuesday announced a deal with MPP - a UN-backed public health organization - to issue royalty-free voluntary licenc...
Pfizer to allow generic versions of its COVID-19 pill in 95 countriesThe voluntary licensing agreement between Pfizer and the MPP will allow the United Nations-backed group to grant sub-licenses to qualified ...
Drug regulator urges Pfizer to apply for vaccine launch“In the light of the pandemic situation, the drug regulatory authority took it up with the company pleading to apply for licensure so that ...
US FDA nod may help speed up Pfizer vaccine rollout in India“India will have to give approval if it has to secure free doses of Pfizer vaccine from the Covax facility,” an official said. “Without giv...
Pfizer rises nearly 2% after it seeks nod for vaccine authorization in IndiaA committee of experts is likely to meet this week to consider Pfizer Inc’s application seeking emergency use authorisation for its Covid v...